Deutsche Bank’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-29,958
Closed -$183K 4413
2021
Q3
$183K Sell
29,958
-938
-3% -$5.73K ﹤0.01% 3578
2021
Q2
$254K Sell
30,896
-9,850
-24% -$81K ﹤0.01% 3613
2021
Q1
$364K Buy
40,746
+7,773
+24% +$69.4K ﹤0.01% 3285
2020
Q4
$380K Sell
32,973
-2,340
-7% -$27K ﹤0.01% 3066
2020
Q3
$367K Sell
35,313
-105,111
-75% -$1.09M ﹤0.01% 2804
2020
Q2
$1.85M Sell
140,424
-504,515
-78% -$6.63M ﹤0.01% 1842
2020
Q1
$5.08M Buy
644,939
+376,536
+140% +$2.96M ﹤0.01% 1230
2019
Q4
$5.56M Sell
268,403
-993
-0.4% -$20.6K ﹤0.01% 1383
2019
Q3
$3.69M Sell
269,396
-34,859
-11% -$478K ﹤0.01% 1553
2019
Q2
$3.74M Buy
304,255
+78,029
+34% +$959K ﹤0.01% 1976
2019
Q1
$2.82M Buy
226,226
+215,380
+1,986% +$2.69M ﹤0.01% 2234
2018
Q4
$122K Sell
10,846
-163,366
-94% -$1.84M ﹤0.01% 3993
2018
Q3
$3.26M Buy
174,212
+96,819
+125% +$1.81M ﹤0.01% 2508
2018
Q2
$2M Sell
77,393
-100,491
-56% -$2.6M ﹤0.01% 2934
2018
Q1
$3.99M Buy
177,884
+100,614
+130% +$2.25M ﹤0.01% 2392
2017
Q4
$1.93M Buy
77,270
+49,987
+183% +$1.25M ﹤0.01% 2721
2017
Q3
$658K Sell
27,283
-16,880
-38% -$407K ﹤0.01% 3214
2017
Q2
$892K Buy
44,163
+37,385
+552% +$755K ﹤0.01% 3061
2017
Q1
$181K Sell
6,778
-9,038
-57% -$241K ﹤0.01% 3495
2016
Q4
$300K Buy
15,816
+10,313
+187% +$196K ﹤0.01% 3354
2016
Q3
$106K Sell
5,503
-8,958
-62% -$173K ﹤0.01% 3726
2016
Q2
$215K Sell
14,461
-34,490
-70% -$513K ﹤0.01% 3620
2016
Q1
$449K Buy
48,951
+42,009
+605% +$385K ﹤0.01% 3219
2015
Q4
$133K Sell
6,942
-37,485
-84% -$718K ﹤0.01% 3734
2015
Q3
$660K Buy
44,427
+41,084
+1,229% +$610K ﹤0.01% 3145
2015
Q2
$73K Sell
3,343
-8,304
-71% -$181K ﹤0.01% 4134
2015
Q1
$262K Buy
11,647
+8,743
+301% +$197K ﹤0.01% 3525
2014
Q4
$58K Buy
2,904
+2,867
+7,749% +$57.3K ﹤0.01% 4646
2014
Q3
$0 Sell
37
-570
-94% ﹤0.01% 5403
2014
Q2
$8K Sell
607
-506
-45% -$6.67K ﹤0.01% 4978
2014
Q1
$17K Buy
+1,113
New +$17K ﹤0.01% 4796